Pradip Nair


Pradip is currently principle scientific manager at Biocon and leads the drug discovery group where he worked extensively in the development of several novel monoclonal antibodies approved in India including BIOMAb™ (anti-EGFR) for head and neck cancers and ALZUMAb™ (itolizumab) for moderate to severe plaque psoriasis. He and his team played a p...

Roles at Equillium

  • Advisor

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.